Pharmacy Website
    Clinic Website

    Intelligence » Anemia » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Norgine buys rights to sell Shield’s iron deficiency therapy

    Wednesday, September 19, 2018 -- Norgine has signed a deal with Shield Therapeutics allowing it to commercialise iron deficiency therapy Feraccru in Europe, Australia and New Zealand.

    Iron Deficiency: The Causes, Detection, and Treatment

    Monday, September 17, 2018 -- The common treatment for iron deficiency anemia is to replenish iron stores through methods such as oral iron or IV (intravenous) iron Continue reading →

    Trial takes FibroGen’s renal anemia drug closer to EU filing

    Thursday, September 20, 2018 -- FibroGen’s partner Astellas has reported phase 3 data that could support filings of their HIF inhibitor in Europe as an oral alternative to EPO drugs.